Skip to main content

MoneyWorks4Me

Glenmark Pharmaceuticals informs about media release

28 Jan 2021 Evaluate

Glenmark Pharmaceuticals has informed that it has enclosed a media release on 28th January 2021 titled ‘Glenmark Pharmaceuticals receives ANDA approval for Amphetamine Sulfate Tablets USP, 5 mg and 10 mg’ which is self-explanatory.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..